th17 cell differentiation (Galectin Therapeutics)
Structured Review

Th17 Cell Differentiation, supplied by Galectin Therapeutics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/th17 cell differentiation/product/Galectin Therapeutics
Average 86 stars, based on 1 article reviews
Images
1) Product Images from "A Narrative Review on the Multifaceted Roles of Galectins in Host–Pathogen Interactions During Helicobacter pylori Infection"
Article Title: A Narrative Review on the Multifaceted Roles of Galectins in Host–Pathogen Interactions During Helicobacter pylori Infection
Journal: International Journal of Molecular Sciences
doi: 10.3390/ijms26157216
Figure Legend Snippet: Molecular pathways of Helicobacter pylori -induced immune activation, immune evasion, and modulation by galectins within the gastric mucosa. H. pylori colonization begins with bacterial motility mediated by flagella, enabling the bacterium to penetrate the gastric mucus layer and adhere to epithelial cells via outer membrane proteins and lipopolysaccharides. The bacterium deploys the type IV secretion system to translocate the CagA effector protein into host epithelial cells, where CagA activates NF-κB signaling. This leads to the upregulation of IL-8 production, driving neutrophil recruitment to the infection site, which exacerbates mucosal inflammation and tissue injury. Simultaneously, VacA toxin enters epithelial cells through endocytosis, where it disrupts mitochondrial membranes, inducing apoptosis of epithelial cells, contributing to mucosal damage. VacA also targets lysosomal membranes, leading to lysosomal dysfunction and oxidative stress, which impairs intracellular pathogen clearance. The immune system responds via Th1 and Th17 polarization, producing IFN-γ and IL-17, respectively, which drive chronic inflammation but are insufficient for bacterial eradication due to immune evasion strategies. H. pylori counters these defenses by promoting the expansion of regulatory T cells (Tregs), partly facilitated by VacA- and CagA-mediated suppression of co-stimulatory signals, which collectively inhibit Th1/Th17 responses and promote immune tolerance within the mucosa. Red arrows mean inhibition, green and black arrows mean activation.
Techniques Used: Activation Assay, Membrane, Infection, Inhibition

